StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
69
This month
3
This week
2
This year
13
Publishing Date
2024 - 04 - 17
2
2024 - 01 - 26
1
2024 - 01 - 25
1
2024 - 01 - 23
1
2024 - 01 - 19
1
2024 - 01 - 17
1
2024 - 01 - 12
1
2023 - 12 - 07
1
2023 - 12 - 04
1
2023 - 11 - 27
1
2023 - 11 - 09
1
2023 - 11 - 01
1
2023 - 10 - 20
1
2023 - 10 - 05
1
2023 - 09 - 06
1
2023 - 09 - 01
1
2023 - 07 - 27
1
2023 - 06 - 05
1
2023 - 06 - 02
2
2023 - 05 - 25
1
2023 - 05 - 04
1
2023 - 05 - 03
1
2023 - 03 - 17
1
2023 - 02 - 08
1
2023 - 02 - 01
1
2023 - 01 - 06
1
2022 - 12 - 19
1
2022 - 12 - 13
1
2022 - 12 - 02
2
2022 - 11 - 09
2
2022 - 11 - 02
1
2022 - 10 - 26
1
2022 - 10 - 21
1
2022 - 09 - 29
1
2022 - 09 - 08
1
2022 - 09 - 07
1
2022 - 07 - 27
1
2022 - 06 - 02
1
2022 - 05 - 31
1
2022 - 05 - 20
1
2022 - 05 - 19
1
2022 - 04 - 28
1
2022 - 04 - 26
1
2022 - 02 - 17
1
2022 - 02 - 04
1
2022 - 01 - 14
1
2021 - 11 - 10
1
2021 - 11 - 03
1
2021 - 10 - 27
1
2021 - 10 - 14
1
2021 - 09 - 08
1
2021 - 08 - 27
1
2021 - 08 - 26
1
2021 - 08 - 03
1
2021 - 07 - 28
1
2021 - 07 - 21
1
2021 - 05 - 12
1
2021 - 04 - 17
1
2021 - 02 - 10
1
2021 - 02 - 02
1
Sector
Commercial services
1
Communications
3
Consumer non-durables
1
Consumer services
1
Distribution services
1
Electronic technology
1
Finance
2
Finance and insurance
1
Health services
1
Health technology
69
Industrial services
1
Manufacturing
1
Mining, quarrying, and oil and gas extraction
1
N/a
1
Process industries
1
Producer manufacturing
1
Retail trade
1
Technology services
1
Utilities
1
Tags
Acquire
1
Als
3
America
1
Antifungal
1
Application
1
Approval
3
Approved
1
Biocapital
11
Bioforest
2
Biomidwest
1
Biopharma
2
Biotech
1
Biotechnology
1
Candidate
4
Care
1
Clinical-trials-phase-iii
1
Communication
1
Conference
8
Covid
1
Designation
2
Diabetic
1
Drug
6
Earnings
2
Enroll
1
Events
2
Fanapt
2
Fda
6
Fda-approvals
1
Financial
9
Financial results
7
Food
2
For
1
Global
3
Granted
2
Growth
1
Health
1
Hetlioz
5
Initiated
1
Internet
1
Jelmyto
1
Market
2
N/a
41
News
2
Partnership
1
Patent
2
People
1
Pharmaceuticals
35
Ponvory
2
Proposal
1
Publication
2
Report
2
Research
5
Resolve
1
Results
21
Study
4
Therapeutics
2
Treatment
9
Trial
2
Vca-894
2
Year
3
Entities
8x8 inc
1
Aarons holdings company, inc.
1
Abbott laboratories
1
Abbvie inc.
1
Acadia pharmaceuticals inc.
1
Adicet bio, inc.
1
Alkermes plc
1
Ally financial inc.
1
Ani pharmaceuticals, inc.
1
Anika therapeutics inc.
1
Apple hospitality reit, inc.
1
Astellas pharma inc
1
Capital trust, inc.
1
Cathay general bancorp
1
Deere & company
1
Eli lilly and company
6
Energizer holdings, inc.
1
Fidelity national financial, inc.
1
Foot locker, inc.
1
Futurefuel corp.
1
G1 therapeutics, inc.
1
Genocea biosciences, inc.
2
Glaxosmithkline plc
2
Glycomimetics, inc.
1
Godaddy inc.
1
Guardant health, inc.
1
Hannon armstrong sustainable infrastructure capital, inc.
1
Hawaiian electric industries, inc.
1
Highwoods properties, inc.
1
Ibio, inc.
2
Johnson & johnson
5
Liberty oilfield services inc.
1
Lincoln national corporation
1
Mallinckrodt plc
1
Moelis & company
1
Newell brands inc.
1
Office properties income trust
1
Orange
3
Pieris pharmaceuticals, inc.
1
Re/max holdings, inc.
1
Regal beloit corporation
1
S&p global inc.
1
Sanofi
1
Sensata technologies holding plc
1
Sensient technologies corporation
1
Syndax pharmaceuticals, inc.
1
Takeda pharmaceutical company limited
1
The blackstone group inc.
1
Trinseo s.a.
1
Uniqure n.v.
1
Universal insurance holdings inc
1
Urogen pharma ltd.
1
Vail resorts, inc.
1
Vanda pharmaceuticals inc.
69
Vaxart, inc.
1
Verona pharma plc
1
Viatris inc.
1
Vistra corp.
1
Waterdrop inc - adr
1
Xeris pharmaceuticals, inc.
1
Symbols
AAPL
1198
ABB
1427
ABBV
1024
ABLZF
1166
ABT
1787
ACN
600
AMGN
742
ARVL
4294
AVGO
593
AZN
665
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7191
FRBA
598
GE
917
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
884
HON
1787
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4583
LLY
1709
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4286
MSFT
1201
MT
589
NOK
901
NOKBF
975
NVO
632
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1477
SAPGF
1231
SNOW
796
SNY
4539
SNYNF
3597
TEVJF
631
TMO
1623
VZ
1213
XYF
676
Exchanges
Amex
2
Nasdaq
69
Nyse
15
Crawled Date
2024 - 04 - 17
2
2024 - 01 - 31
1
2024 - 01 - 30
1
2024 - 01 - 26
1
2024 - 01 - 25
1
2024 - 01 - 23
1
2024 - 01 - 19
1
2024 - 01 - 17
1
2024 - 01 - 12
1
2023 - 12 - 07
1
2023 - 12 - 04
1
2023 - 11 - 27
1
2023 - 11 - 09
1
2023 - 11 - 01
1
2023 - 10 - 20
1
2023 - 10 - 05
1
2023 - 09 - 06
1
2023 - 09 - 01
1
2023 - 07 - 27
1
2023 - 06 - 05
1
2023 - 06 - 02
2
2023 - 05 - 25
1
2023 - 05 - 04
2
2023 - 03 - 17
1
2023 - 02 - 08
1
2023 - 02 - 02
1
2023 - 01 - 06
1
2022 - 12 - 19
1
2022 - 12 - 14
1
2022 - 12 - 02
2
2022 - 11 - 09
2
2022 - 11 - 02
1
2022 - 10 - 26
1
2022 - 10 - 21
1
2022 - 09 - 29
1
2022 - 09 - 08
1
2022 - 09 - 07
1
2022 - 07 - 27
1
2022 - 06 - 03
1
2022 - 05 - 31
1
2022 - 05 - 20
2
2022 - 04 - 28
1
2022 - 04 - 26
1
2022 - 02 - 18
1
2022 - 02 - 04
1
2022 - 01 - 14
1
2021 - 11 - 11
1
2021 - 11 - 03
1
2021 - 10 - 27
1
2021 - 10 - 14
1
2021 - 09 - 08
1
2021 - 08 - 27
1
2021 - 08 - 26
1
2021 - 08 - 03
1
2021 - 07 - 28
1
2021 - 07 - 21
1
2021 - 05 - 12
1
2021 - 04 - 17
1
2021 - 02 - 10
1
2021 - 02 - 02
1
Crawled Time
00:00
6
01:00
3
02:00
3
04:00
1
04:20
1
07:00
1
11:00
2
12:00
4
12:20
4
12:30
1
13:00
2
14:00
1
14:30
1
15:00
2
15:30
1
16:00
1
17:00
1
20:00
2
21:00
9
21:11
1
22:00
7
23:00
15
Source
www.biospace.com
28
www.globenewswire.com
1
www.prnewswire.com
40
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
VNDA
save search
Future Pak Confirms Proposal to Acquire Vanda Pharmaceuticals for $7.25 to $7.75 Per Share in Cash
Published:
2024-04-17
(Crawled : 12:00)
- biospace.com/
MC
|
$51.65
1.33%
0.0%
590K
|
Finance
|
0.15%
|
O:
0.56%
H:
0.8%
C:
-0.41%
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
31.0%
|
O:
35.5%
H:
4.61%
C:
-3.32%
pharmaceuticals
acquire
for
proposal
Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak
Published:
2024-04-17
(Crawled : 13:00)
- prnewswire.com
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
31.0%
|
O:
35.5%
H:
4.61%
C:
-3.32%
unsolicited
pharmaceuticals
Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder
Published:
2024-04-02
(Crawled : 23:00)
- biospace.com/
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
27.18%
|
O:
-2.43%
H:
0.0%
C:
-2.74%
fanapt
fda
approval
treatment
Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia
Published:
2024-03-06
(Crawled : 12:00)
- prnewswire.com
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
26.57%
|
O:
-1.21%
H:
0.0%
C:
-4.4%
hetlioz
fda
update
treatment
pharmaceuticals
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-02-07
(Crawled : 21:00)
- prnewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-5.11%
|
O:
-2.28%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.28%
|
O:
-0.63%
H:
0.0%
C:
0.0%
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
43.96%
|
O:
0.27%
H:
20.82%
C:
11.51%
year
pharmaceuticals
financial
results
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VTR-297 a Topical Antifungal Candidate for the Treatment of Onychomycosis
Published:
2024-01-31
(Crawled : 14:30)
- biospace.com/
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
43.56%
|
O:
1.37%
H:
1.35%
C:
-2.7%
vtr-297
fda
drug
candidate
approval
treatment
pharmaceuticals
antifungal
Court Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag Hearing Request by March 5, 2024
Published:
2024-01-30
(Crawled : 00:00)
- prnewswire.com
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
37.89%
|
O:
0.0%
H:
0.26%
C:
-3.95%
fda
resolve
Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.
Published:
2024-01-26
(Crawled : 04:00)
- prnewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.89%
|
O:
0.8%
H:
0.0%
C:
0.0%
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
38.26%
|
O:
0.79%
H:
1.05%
C:
-1.83%
ponvory
patent
pharmaceuticals
Vanda Pharmaceuticals announces the publication of an article on The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial
Published:
2024-01-25
(Crawled : 22:00)
- biospace.com/
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
18.47%
|
O:
-1.0%
H:
0.84%
C:
0.04%
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
42.78%
|
O:
2.72%
H:
0.53%
C:
0.53%
publication
pharmaceuticals
trial
diabetic
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S
Published:
2024-01-23
(Crawled : 15:30)
- biospace.com/
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
38.26%
|
O:
2.11%
H:
1.03%
C:
-4.13%
vca-894
fda
drug
candidate
approval
treatment
pharmaceuticals
Federal Court Allows Vanda Pharmaceuticals' Lawsuit to Proceed Against the U.S. Food and Drug Administration
Published:
2024-01-19
(Crawled : 21:00)
- prnewswire.com
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
drug
food
Vanda Pharmaceuticals announces the publication of Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study in the Journal of Clinical Psychiatry
Published:
2024-01-17
(Crawled : 21:00)
- prnewswire.com
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
39.36%
|
O:
0.27%
H:
1.19%
C:
-2.12%
publication
pharmaceuticals
study
Vanda Pharmaceuticals Comments on FDA's Recently Announced Guidance on Communication with Health Care Professionals Regarding FDA-Approved Drugs
Published:
2024-01-12
(Crawled : 22:00)
- biospace.com/
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
33.67%
|
O:
0.77%
H:
1.27%
C:
-2.53%
health
care
pharmaceuticals
communication
Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORY® (ponesimod), a Selective S1P1R Modulator Approved for Patients with Relapsing Multiple Sclerosis
Published:
2023-12-07
(Crawled : 12:00)
- prnewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.57%
|
O:
-1.61%
H:
0.0%
C:
0.0%
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
29.7%
|
O:
6.68%
H:
1.39%
C:
-7.89%
ponvory
approved
sclerosis
pharmaceuticals
Vanda Pharmaceuticals Announces that U.S. Food and Drug Administration Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis
Published:
2023-12-04
(Crawled : 23:00)
- prnewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
28.91%
|
O:
0.08%
H:
0.0%
C:
0.0%
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
36.1%
|
O:
2.08%
H:
1.53%
C:
0.76%
drug
food
treatment
pharmaceuticals
application
Insomnia Therapeutics Market to grow by USD 1 billion from 2022-2027 | North America to account for 60% of market growth - Technavio
Published:
2023-11-27
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.28%
|
O:
-1.89%
H:
0.02%
C:
0.02%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-23.82%
|
O:
-4.49%
H:
6.23%
C:
3.42%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
19.06%
|
O:
-0.21%
H:
0.21%
C:
-1.93%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-6.54%
|
O:
-0.07%
H:
0.28%
C:
0.21%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
3.59%
|
O:
-0.24%
H:
0.03%
C:
-0.39%
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
47.19%
|
O:
2.81%
H:
0.0%
C:
-3.01%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.49%
|
O:
-1.41%
H:
0.87%
C:
0.0%
america
therapeutics
growth
market
Vanda Pharmaceuticals Announces Participation at November 2023 Investor Conferences
Published:
2023-11-09
(Crawled : 23:00)
- biospace.com/
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
21.02%
|
O:
-3.46%
H:
1.91%
C:
-19.14%
pharmaceuticals
Vanda Pharmaceuticals to Announce Third Quarter 2023 Financial Results on November 8, 2023
Published:
2023-11-01
(Crawled : 21:00)
- prnewswire.com
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
19.91%
|
O:
-0.23%
H:
2.98%
C:
2.52%
pharmaceuticals
financial
results
Vanda Pharmaceuticals Intends to Petition the U.S. Supreme Court in its HETLIOZ® ANDA Litigation
Published:
2023-10-20
(Crawled : 11:00)
- prnewswire.com
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
21.58%
|
O:
-0.23%
H:
2.79%
C:
0.93%
hetlioz
pharmaceuticals
Vanda Pharmaceuticals Announces Participation in the Jefferies Inaugural Biotech CNS/Neuro Summit
Published:
2023-10-05
(Crawled : 23:00)
- prnewswire.com
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
17.49%
|
O:
2.02%
H:
2.86%
C:
0.66%
biotech
pharmaceuticals
← Previous
1
2
3
4
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.